Bartlett & Co Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bartlett & Co Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Buy	575 +5	+0.9%	+$2.22K	﹤0.01%	429
2026 Q1	$245K	Sell	570 -31	-5%	-$14.5K	﹤0.01%	427
2025 Q4	$272K	Buy	601 +1	+0.2%	+$431	﹤0.01%	415
2025 Q3	$235K	Buy	600 +13	+2%	+$5.43K	﹤0.01%	428
2025 Q2	$261K	Hold	587	–	–	﹤0.01%	409
2025 Q1	$285K	Buy	587 +230	+64%	+$107K	﹤0.01%	403
2024 Q4	$144K	Hold	357	–	–	﹤0.01%	490
2024 Q3	$166K	Buy	357 +6	+2%	+$2.88K	﹤0.01%	473
2024 Q2	$165K	Buy	351 +96	+38%	+$41.7K	﹤0.01%	460
2024 Q1	$107K	Buy	255 +55	+28%	+$23.3K	﹤0.01%	542
2023 Q4	$81.9K	Hold	200	–	–	﹤0.01%	606
2023 Q3	$69.5K	Hold	200	–	–	﹤0.01%	595
2023 Q2	$70.4K	Hold	200	–	–	﹤0.01%	600
2023 Q1	$63K	Hold	200	–	–	﹤0.01%	535
2022 Q4	$57.8K	Hold	200	–	–	﹤0.01%	560
2022 Q3	$57.9K	Hold	200	–	–	﹤0.01%	546
2022 Q2	$56.4K	Hold	200	–	–	﹤0.01%	551
2022 Q1	$52.2K	Buy	+200	New	+$47.5K	﹤0.01%	578
2021 Q3	–	Sell	-4	Closed	-$807	–	1082
2021 Q2	$807	Sell	4 -50	-93%	-$10.5K	﹤0.01%	978
2021 Q1	$11.6K	Hold	54	–	–	﹤0.01%	712
2020 Q4	$12.8K	Buy	54 +4	+8%	+$918	﹤0.01%	708
2020 Q3	$13.6K	Hold	50	–	–	﹤0.01%	658
2020 Q2	$14.5K	Buy	+50	New	+$13.6K	﹤0.01%	646
2019 Q3	–	Sell	-34	Closed	-$6.24K	–	938
2019 Q2	$6.24K	Buy	+34	New	+$5.94K	﹤0.01%	617

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bartlett & Co Wealth Management's VRTX Position: Q2 2026 in Review

Bartlett & Co Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.88% in Q2 2026, buying an estimated $2.22K and bringing the position to 575 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

Bartlett & Co Wealth Management first reported a position in VRTX in Q2 2019 and has held it in 24 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Bartlett & Co Wealth Management held 575 shares of Vertex Pharmaceuticals worth $286K as of Q2 2026.
Bartlett & Co Wealth Management bought 5 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.22K.
Vertex Pharmaceuticals made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #429 holding.
Bartlett & Co Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 24 quarters since.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.